{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:32:32Z","timestamp":1792211552242,"version":"4.4.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY034672"],"award-info":[{"award-number":["R01EY034672"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jtos.2023.09.006","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T02:22:58Z","timestamp":1695349378000},"page":"179-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Murine models of graft versus host disease (GVHD): Focus on ocular GVHD"],"prefix":"10.1016","volume":"30","author":[{"given":"Philipp","family":"Steven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8947-607X","authenticated-orcid":false,"given":"Ajay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jtos.2023.09.006_bib1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jtct.2021.06.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2020 highly morbid forms report","volume":"27","author":"Wolff","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtos.2023.09.006_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtos.2023.09.006_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","article-title":"Acute graft-versus-host disease","volume":"9","author":"Malard","year":"2023","journal-title":"Nat Rev Dis Prim"},{"issue":"2","key":"10.1016\/j.jtos.2023.09.006_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nrclinonc.2015.234","article-title":"Modern approaches to HLA-haploidentical blood or marrow transplantation","volume":"13","author":"Kanakry","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"26","key":"10.1016\/j.jtos.2023.09.006_bib5","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jtos.2023.09.006_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jtct.2021.03.033","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IIa. The 2020 clinical implementation and early diagnosis working group report","volume":"27","author":"Kitko","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtos.2023.09.006_bib7","doi-asserted-by":"crossref","first-page":"962250","DOI":"10.3389\/fonc.2022.962250","article-title":"Corneal perforation associated with ocular graft-versus-host disease","volume":"12","author":"Xu","year":"2022","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.jtos.2023.09.006_bib8","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1007\/s10792-021-01811-3","article-title":"Ophthalmologic findings and complications before and after hematopoietic stem cell transplantation: single-center study","volume":"41","author":"Sarbay","year":"2021","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jtos.2023.09.006_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ajo.2021.02.022","article-title":"Incidence, risk factors and complications of ocular graft-versus-host disease following hematopoietic stem cell transplantation","volume":"227","author":"Pellegrini","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2023.09.006_bib10","first-page":"2613","article-title":"Outcomes and complications of cataract surgery in patients with chronic ocular graft-versus-host-disease-a multicenter, retrospective analysis","volume":"260","author":"Gehlsen","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2023.09.006_bib11","first-page":"697","volume":"68","author":"Soleimani","year":"2023","journal-title":"Ocular graft-versus-host disease (oGVHD): From A to Z. Surv Ophthalmol"},{"issue":"11","key":"10.1016\/j.jtos.2023.09.006_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22116114","article-title":"Cascade of inflammatory, fibrotic processes, and stress-induced senescence in chronic GVHD-related dry eye disease","volume":"22","author":"Ogawa","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"13","key":"10.1016\/j.jtos.2023.09.006_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/iovs.62.13.10","article-title":"Local renin-angiotensin system activation and myofibroblast formation in graft versus host disease-associated conjunctival fibrosis","volume":"62","author":"Shamloo","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2023.09.006_bib14","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1167\/iovs.14-15630","article-title":"Recruitment of donor T cells to the eyes during ocular GVHD in recipients of MHC-matched allogeneic hematopoietic stem cell transplants","volume":"56","author":"Herretes","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"14","key":"10.1016\/j.jtos.2023.09.006_bib15","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1167\/iovs.19-27843","article-title":"Graft versus host disease-associated dry eye: role of ocular surface mucins and the effect of rebamipide, a mucin secretagogue","volume":"60","author":"Shamloo","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.09.006_bib16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jtos.2021.10.006","article-title":"Eyelid blood vessel and meibomian gland changes in a sclerodermatous chronic GVHD mouse model","volume":"26","author":"Yang","year":"2022","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2023.09.006_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajo.2022.09.009","article-title":"Meibomian gland dysfunction: a route of ocular graft-versus-host disease progression that drives a vicious cycle of ocular surface inflammatory damage","volume":"247","author":"Perez","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2023.09.006_bib18","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1167\/iovs.15-18615","article-title":"Biomarkers in ocular chronic graft versus host disease: tear cytokine- and chemokine-based predictive model","volume":"57","author":"Cocho","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.jtos.2023.09.006_bib19","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1167\/iovs.15-16736","article-title":"Gene expression-based predictive models of graft versus host disease-associated dry eye","volume":"56","author":"Cocho","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2023.09.006_bib20","doi-asserted-by":"crossref","first-page":"12985","DOI":"10.1038\/s41598-022-17032-2","article-title":"Long-term clinical outcomes and predictive factors in patients with chronic ocular graft-versus-host disease","volume":"12","author":"Yoon","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2023.09.006_bib21","doi-asserted-by":"crossref","unstructured":"Gehlsen U, Stern ME, Franklin J, Tahmaz V, Hallek M, Holtick U, et al. Desiccating stress significantly increases the risk for chronic ocular graft-versus-host-disease. Transplant Cell Ther;28(11):782e1-e7.","DOI":"10.1016\/j.jtct.2022.07.027"},{"key":"10.1016\/j.jtos.2023.09.006_bib22","series-title":"The major histocompatibility complex and its encoded proteins, in Paul: fundamental immunology 5th edition","author":"Margulies","year":"2003"},{"issue":"13","key":"10.1016\/j.jtos.2023.09.006_bib23","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","article-title":"High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation","volume":"110","author":"Lee","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtos.2023.09.006_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.bmt.1703328","article-title":"A two-phase pathogenesis of graft-versus-host disease in mice","volume":"29","author":"van Leeuwen","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtos.2023.09.006_bib25","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1084\/jem.20130084","article-title":"The Nlrp3 inflammasome regulates acute graft-versus-host disease","volume":"210","author":"Jankovic","year":"2013","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.jtos.2023.09.006_bib26","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood.V78.11.3093.3093","article-title":"Prevention of murine graft-versus-host disease and bone marrow alloengraftment across the major histocompatibility barrier after donor graft preincubation with anti-LFA1 immunotoxin","volume":"78","author":"Blazar","year":"1991","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtos.2023.09.006_bib27","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1182\/blood.V92.10.3960","article-title":"Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice","volume":"92","author":"Panoskaltsis-Mortari","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jtos.2023.09.006_bib28","series-title":"Mouse models of graft-versus-host disease, in StemBook [Internet]","author":"Reddy","year":"2008"},{"key":"10.1016\/j.jtos.2023.09.006_bib29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fimmu.2016.00333","article-title":"The role of animal models in the study of hematopoietic stem cell transplantation and GvHD: a historical overview","volume":"7","author":"Boieri","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtos.2023.09.006_bib30","doi-asserted-by":"crossref","first-page":"715893","DOI":"10.3389\/fimmu.2021.715893","article-title":"Mouse models of antigen presentation in hematopoietic stem cell transplantation","volume":"12","author":"Koyama","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jtos.2023.09.006_bib31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1084\/jem.163.4.998","article-title":"Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences","volume":"163","author":"Sprent","year":"1986","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.jtos.2023.09.006_bib32","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.4049\/jimmunol.144.8.2946","article-title":"Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. II. Protective effects of L3T4+ cells in anti-class II GVHD","volume":"144","author":"Sprent","year":"1990","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.jtos.2023.09.006_bib33","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1182\/blood-2006-12-063982","article-title":"IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract","volume":"110","author":"Burman","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtos.2023.09.006_bib34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbmt.2009.09.023","article-title":"T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease","volume":"16","author":"Iclozan","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtos.2023.09.006_bib35","doi-asserted-by":"crossref","first-page":"715424","DOI":"10.3389\/fimmu.2021.715424","article-title":"The pathophysiology and treatment of graft-versus-host disease: lessons learnt from animal models","volume":"12","author":"Teshima","year":"2021","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.jtos.2023.09.006_bib36","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1097\/00007890-200005270-00040","article-title":"Apoptosis of thymocytes during acute graft-versus-host disease is independent of glucocorticoids","volume":"69","author":"Krenger","year":"2000","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.jtos.2023.09.006_bib37","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1182\/blood-2003-12-4259","article-title":"Donor-derived TNF-alpha regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation","volume":"104","author":"Hildebrandt","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtos.2023.09.006_bib38","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1182\/blood-2004-05-1687","article-title":"Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease","volume":"105","author":"Blaser","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtos.2023.09.006_bib39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fimmu.2018.00010","article-title":"Simple, reproducible, and efficient clinical grading system for murine models of acute graft-versus-host disease","volume":"9","author":"Naserian","year":"2018","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.jtos.2023.09.006_bib40","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.4049\/jimmunol.157.11.4811","article-title":"Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease","volume":"157","author":"Fowler","year":"1996","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.jtos.2023.09.006_bib41","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.4049\/jimmunol.172.5.3328","article-title":"Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease","volume":"172","author":"Gendelman","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jtos.2023.09.006_bib42","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.175.2.405","article-title":"Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease","volume":"175","author":"Nestel","year":"1992","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.jtos.2023.09.006_bib43","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1084\/jem.165.6.1552","article-title":"Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice","volume":"165","author":"Korngold","year":"1987","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.jtos.2023.09.006_bib44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.bbmt.2005.02.002","article-title":"Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers","volume":"11","author":"Eyrich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtos.2023.09.006_bib45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/bbmt.2001.v7.pm11215694","article-title":"Vbeta spectra type analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate","volume":"7","author":"Friedman","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtos.2023.09.006_bib46","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00007890-199404150-00019","article-title":"T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens","volume":"57","author":"Berger","year":"1994","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.jtos.2023.09.006_bib47","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.4049\/jimmunol.173.9.5467","article-title":"Target antigens determine graft-versus-host disease phenotype","volume":"173","author":"Kaplan","year":"2004","journal-title":"J Immunol"},{"issue":"1 Suppl 1","key":"10.1016\/j.jtos.2023.09.006_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbmt.2007.10.021","article-title":"Mouse models of bone marrow transplantation","volume":"14","author":"Reddy","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtos.2023.09.006_bib49","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1242\/dmm.006668","article-title":"Mouse models of graft-versus-host disease: advances and limitations","volume":"4","author":"Schroeder","year":"2011","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jtos.2023.09.006_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.700857","article-title":"Murine models provide new insights into pathogenesis of chronic graft-versus-host disease in humans","volume":"12","author":"Song","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtos.2023.09.006_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.723544","article-title":"Capitini CM. GVHD pathogenesis, prevention and treatment: lessons from humanized mouse transplant models","volume":"12","author":"Hess","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jtos.2023.09.006_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0008-8749(83)90001-1","article-title":"Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems","volume":"77","author":"Jaffee","year":"1983","journal-title":"Cell Immunol"},{"issue":"10","key":"10.1016\/j.jtos.2023.09.006_bib53","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.163.10.5693","article-title":"Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma","volume":"163","author":"McCormick","year":"1999","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.jtos.2023.09.006_bib54","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/sj.bmt.1702383","article-title":"Parotid salivary gland dysfunction in chronic graft-versus-host disease (cGVHD): a longitudinal study in a mouse model","volume":"25","author":"Levy","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtos.2023.09.006_bib55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.jid.5700517","article-title":"Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma","volume":"127","author":"Zhou","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jtos.2023.09.006_bib56","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4049\/jimmunol.143.2.476","article-title":"Hepatic homing of mononuclear inflammatory cells isolated during murine chronic graft-vs-host disease","volume":"143","author":"Howell","year":"1989","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.jtos.2023.09.006_bib57","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.4049\/jimmunol.136.10.3549","article-title":"Clonal analysis of murine graft-vs-host disease. II. Leukokines that stimulate fibroblast proliferation and collagen synthesis in graft-vs. host disease","volume":"136","author":"DeClerck","year":"1986","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.jtos.2023.09.006_bib58","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1172\/JCI75328","article-title":"Ibrutinib treatment ameliorates murine chronic graft-versus-host disease","volume":"124","author":"Dubovsky","year":"2014","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.jtos.2023.09.006_bib59","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.4049\/jimmunol.139.8.2511","article-title":"L3T4-positive T cells participate in the induction of graft-vs-host disease in response to minor histocompatibility antigens","volume":"139","author":"Hamilton","year":"1987","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.jtos.2023.09.006_bib60","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1747.2003.12517.x","article-title":"Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma","volume":"121","author":"Zhang","year":"2003","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jtos.2023.09.006_bib61","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.4049\/jimmunol.134.3.1475","article-title":"Chronic progressive polyarthritis and other symptoms of collagen vascular disease induced by graft-vs-host reaction","volume":"134","author":"Pals","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2023.09.006_bib62","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-60761-720-4_12","article-title":"The parent-into-F1 murine model in the study of lupus-like autoimmunity and CD8 cytotoxic T lymphocyte function","volume":"900","author":"Soloviova","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"5","key":"10.1016\/j.jtos.2023.09.006_bib63","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1023\/A:1006676315093","article-title":"T-cell activation and differentiation are regulated by TNF during murine DBA\/2-->B6D2F1 intestinal graft-versus-host disease","volume":"20","author":"Brown","year":"2000","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.jtos.2023.09.006_bib64","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1172\/JCI114383","article-title":"Intestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes","volume":"84","author":"Thiele","year":"1989","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.jtos.2023.09.006_bib65","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.bmt.1702661","article-title":"Genetic factors influencing the development of chronic graft-versus-host disease in a murine model","volume":"26","author":"Slayback","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtos.2023.09.006_bib66","doi-asserted-by":"crossref","first-page":"559740","DOI":"10.3389\/fimmu.2020.559740","article-title":"IL-Y aggravates murine chronic graft-versus-host disease by enhancing T and B cell responses","volume":"11","author":"Wan","year":"2020","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.jtos.2023.09.006_bib67","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1182\/blood-2005-09-3623","article-title":"Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations","volume":"107","author":"Zhang","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtos.2023.09.006_bib68","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.4049\/jimmunol.165.10.5987","article-title":"Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease","volume":"165","author":"Tschetter","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jtos.2023.09.006_bib69","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.157.2.755","article-title":"Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and\/or I-A","volume":"157","author":"Rolink","year":"1983","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.jtos.2023.09.006_bib70","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/08916939209150313","article-title":"Histological characteristics of lupus nephritis in F1 mice with chronic graft-versus-host reaction across MHC class II difference","volume":"12","author":"Ito","year":"1992","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.jtos.2023.09.006_bib71","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1182\/blood-2006-08-042853","article-title":"Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease","volume":"109","author":"Sakoda","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtos.2023.09.006_bib72","first-page":"359","article-title":"Animal models of graft-versus-host disease","volume":"8","author":"Zeiser","year":"2014","journal-title":"Hematol Educ"},{"key":"10.1016\/j.jtos.2023.09.006_bib73","doi-asserted-by":"crossref","first-page":"1639012","DOI":"10.1155\/2017\/1639012","article-title":"Reduced expression of VAMP8 in lacrimal gland affected by chronic graft-versus-host disease","volume":"2017","author":"Fukui","year":"2017","journal-title":"J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2023.09.006_bib74","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3390\/diagnostics11081515","article-title":"Observation of chronic graft-versus-host disease mouse model cornea with in vivo confocal microscopy","volume":"11","author":"Shimizu","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.jtos.2023.09.006_bib75","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.09394","article-title":"MHC-compatible bone marrow stromal\/stem cells trigger fibrosis by activating host T cells in a scleroderma mouse model","volume":"5","author":"Ogawa","year":"2016","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.jtos.2023.09.006_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064724","article-title":"Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host disease","volume":"8","author":"Yaguchi","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jtos.2023.09.006_bib77","doi-asserted-by":"crossref","first-page":"10778","DOI":"10.1096\/fj.201900218R","article-title":"Senescence-associated secretory phenotype promotes chronic ocular graft-vs-host disease in mice and humans","volume":"34","author":"Yamane","year":"2020","journal-title":"Faseb J"},{"issue":"8","key":"10.1016\/j.jtos.2023.09.006_bib78","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1096\/fj.201700176R","article-title":"Inhibition of vascular adhesion protein-1 for treatment of graft-versus-host disease in mice","volume":"32","author":"Mukai","year":"2018","journal-title":"Faseb J"},{"issue":"10","key":"10.1016\/j.jtos.2023.09.006_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203742","article-title":"Therapeutic potential of tranilast for the treatment of chronic graft-versus-host disease in mice","volume":"13","author":"Mukai","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2023.09.006_bib80","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1038\/srep02455","article-title":"Expression and localization of aging markers in lacrimal gland of chronic graft-versus-host disease","volume":"3","author":"Kawai","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2023.09.006_bib81","doi-asserted-by":"crossref","first-page":"41939","DOI":"10.1038\/srep41939","article-title":"Novel treatment of chronic graft-versus-host disease in mice using the ER stress reducer 4-phenylbutyric acid","volume":"7","author":"Mukai","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.jtos.2023.09.006_bib82","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.3390\/ijms22126191","article-title":"Ocular graft-versus-host disease in a chemotherapy-based minor-mismatch mouse model features corneal (lymph-) angiogenesis","volume":"22","author":"Gehlsen","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.jtos.2023.09.006_bib83","article-title":"Adverse environmental stress is a risk factor for ocular graft-versus-host disease. Invest Ophthalmol","volume":"62","author":"Steven","year":"2021","journal-title":"Vis Sci"},{"key":"10.1016\/j.jtos.2023.09.006_bib84","doi-asserted-by":"crossref","unstructured":"Perez VL, Barsam A, Duffort S, Urbieta M, Barreras H, Lightbourn C, et al. Novel scoring criteria for the evaluation of ocular graft-versus-host disease in a preclinical allogeneic hematopoietic stem cell transplantation animal model. Biol Blood Marrow Transplant;22(10):1765-1772.","DOI":"10.1016\/j.bbmt.2016.07.012"},{"issue":"1","key":"10.1016\/j.jtos.2023.09.006_bib85","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/ijms23010184","article-title":"Analyses and correlation of pathologic and ocular cutaneous changes in murine graft versus host disease","volume":"23","author":"Levy","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2023.09.006_bib86","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48378","article-title":"Complement and CD4+T cells drive context-specific corneal sensory neuropathy","volume":"8","author":"Royer","year":"2019","journal-title":"Elife"},{"issue":"19","key":"10.1016\/j.jtos.2023.09.006_bib87","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122430","article-title":"SYK inhibitor entospletinib prevents ocular and skin GVHD in mice","volume":"3","author":"Poe","year":"2018","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.jtos.2023.09.006_bib88","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.bbmt.2019.08.001","article-title":"Modeling chronic graft-versus-host disease in MHC-matched mouse strains: genetics, graft composition, and tissue targets","volume":"25","author":"M\u00fcller","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4075","key":"10.1016\/j.jtos.2023.09.006_bib89","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.179.4075.811","article-title":"Graft versus leukemia: quantification of adoptive immunotherapy in murine leukemia","volume":"179","author":"Bortin","year":"1973","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.jtos.2023.09.006_bib90","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","article-title":"Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts","volume":"300","author":"Weiden","year":"1979","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jtos.2023.09.006_bib91","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtos.2023.09.006_bib92","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/JLB.5AB0820-542RR","article-title":"A novel clinically relevant graft-versus-leukemia model in humanized mice","volume":"111","author":"Jia","year":"2022","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.jtos.2023.09.006_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245232","article-title":"Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models","volume":"16","author":"Mashima","year":"2021","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jtos.2023.09.006_bib94","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3727\/096368912X657666","article-title":"Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia","volume":"22","author":"Oviedo","year":"2013","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jtos.2023.09.006_bib95","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.3389\/fimmu.2018.03041","article-title":"Strategies for enhancing and preserving anti-leukemia effects without aggravating graft-versus-host disease","volume":"9","author":"Chang","year":"2018","journal-title":"Front Immunol"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012423001246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012423001246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:47:07Z","timestamp":1761540427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012423001246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":95,"alternative-id":["S1542012423001246"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2023.09.006","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Murine models of graft versus host disease (GVHD): Focus on ocular GVHD","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2023.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}